Managed Account Advisors’s Emergent Biosolutions EBS Stock Holding History

Managed Account Advisors’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$2.72M	Sell	82,487 -5,408	-6%	-$168K	﹤0.01%	1711
2015 Q1	$2.53M	Buy	87,895 +9,001	+11%	+$258K	﹤0.01%	1735
2014 Q4	$2.15M	Sell	78,894 -4,517	-5%	-$108K	﹤0.01%	1785
2014 Q3	$1.78M	Buy	83,411 +20,690	+33%	+$474K	﹤0.01%	1852
2014 Q2	$1.41M	Buy	62,721 +8,124	+15%	+$189K	﹤0.01%	1916
2014 Q1	$1.38M	Buy	+54,597	New	+$1.38M	﹤0.01%	1861

Other funds holding EBS

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

FMA

Fiduciary Management Associates Chicago, Illinois $1.53B AUM 4.47% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Managed Account Advisors's EBS Position: Q2 2015 in Review

Managed Account Advisors reduced its Emergent Biosolutions (EBS) stake by 6.2% in Q2 2015, selling an estimated $168K and leaving 82,487 shares worth $2.72M. The position accounts for ﹤0.01% of the portfolio, ranked #1711.

Managed Account Advisors first reported a position in EBS in Q1 2014 and has held it in 6 quarters since. 184 funds tracked by Wall St. Rank hold EBS as of Q2 2015.

Managed Account Advisors held 82,487 shares of Emergent Biosolutions worth $2.72M as of Q2 2015.
Managed Account Advisors sold 5,408 Emergent Biosolutions shares in Q2 2015, an estimated $168K.
Emergent Biosolutions made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #1711 holding.
Managed Account Advisors first reported a position in Emergent Biosolutions in Q1 2014 and has held it in 6 quarters since.
184 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.